Potential basis for amphotericin B resistance in Aspergillus terreus

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 4, 2008, Pages 1553-1555

  Blum, Gerhard ^a   Perkhofer, Susanne ^a   Haas, Hubertus ^a   Schrettl, Markus ^a   Würzner, Reinhard ^a   Dierich, Manfred P ^a   Lass Flörl, Cornelia ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CATALASE; ERGOSTEROL;

ANTIBIOTIC RESISTANCE; ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; CONTROLLED STUDY; ENZYME SYNTHESIS; FUNGAL CELL; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; CATALASE; DRUG RESISTANCE, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 42049089497     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01280-07     Document Type: Article

References (25)

1. Aebi, H. 1984. Catalase in vitro. Methods Enzymol. 105:121-126.
2. Arthington-Skaggs, B. A., H. Jradi, T. Desai, and C. J. Morrison. 1999. Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans. J. Clin. Microbiol. 37:3332-3337.
3. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
4. Breivik, O. N., and J. L. Owades. 1957. Spectrophotometric semi-microdetermination of ergosterol in yeast. Agric. Food Chem. 5:360-363.
5. Buckova, M., J. Godocikova, A. Simonovicova, and B. Polek. 2005. Production of catalases by Aspergillus niger isolates as a response to pollutant stress by heavy metals. Curr. Microbiol. 50:175-179.
6. Buege, J. A., and S. D. Aust. 1978. Microsomal lipid peroxidation. Methods Enzymol. 52:302-310.
7. Dannaoui, E., E. Borel, F. Persat, M. A. Piens, and S. Picot. 1999. Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis. J. Med. Microbiol. 49:601-606.
8. Dannaoui, E., F. Persat, M. F. Monier, E. Borel, M. A. Piens, and S. Picot. 1999. In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole. J. Antimicrob. Chemother. 44:553-555.
9. Reference deleted.
10. Hearn, V. M., E. V. Wilson, and D. W. Mackenzie. 1980. The preparation of protoplasts from Aspergillus fumigatus mycelium. Sabouraudia 18:75-77.
11. Joseph-Horne, T., N. Manning, D. Holoman, and S. Kelly. 1996. Nonsterol related resistance in Ustilago maydis to the polyene antifungals, amphotericin B and nystatin. Phytochemistry 42:637-639.
12. Kagan, V. E. 1988. Lipid peroxidation in biomembranes. CRC Press Inc., Boca Raton, FL.
13. Kawasaki, L., D. Wysong, R. Diamond, and J. Aguirre. 1997. Two divergent catalase genes are differentially regulated during Aspergillus nidulans development and oxidative stress. J. Bacteriol. 179:3284-3292.
14. Reference deleted.
15. Moore, C. B., D. Law, and D. W. Denning. 1993. In-vitro activity of the new triazole D0870 compared with amphotericin B and itraconazole against Aspergillus spp. J. Antimicrob. Chemother. 32:831-836.
16. National Committee for Clinical Laboratory Standards. 2002. Reference methods for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
17. Oakley, K. L., C. B. Moore, and D. W. Denning. 1999. Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole. Antimicrob. Agents Chemother. 43:1264-1266.
18. Peever, T. L., and V. J. Higgins. 1989. Electrolyte leakage, lipoxygenase, and lipid peroxidation induced in tomato leaf tissue by specific and nonspecific elicitors from Cladosporium fulvum. Plant Physiol. 90:867-875.
19. Pierce, A. M., H. D. Pierce, A. M. Unrau, and A. C. Oehlschlager. 1978. Lipid composition and polyene antibiotic resistance of Candida albicans mutants. Can. J. Biochem. 56:135-142.
20. Seo, K., H. Akiyoshi, and Y. Ohnishi. 1999. Alteration of cell wall composition leads to amphotericin B resistance in Aspergillus flavus. Microbiol. Immunol. 43:1017-1025.
21. Sokol-Anderson, M. L., J. Brajtburg, and G. Medoff. 1986. Amphotericin B-induced oxidative damage and killing of Candida albicans. J. Infect. Dis. 154:76-83.
22. Sterling, T. R., and W. G. Merz. 1998. Resistance to amphotericin B: emerging clinical and microbiological patterns. Drug Resist. Updat. 1:161-165.
23. Sutton, D. A., S. E. Sanche, S. G. Revankar, A. W. Fothergill, and M. G. Rinaldi. 1999. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. J. Clin. Microbiol. 37:2343-2345.
24. Vanden Bossche, H., D. W. Warnock, B. Dupont, D. Kerridge, S. Sen Gupta, L. Improvisi, P. Marichal, F. C. Odds, F. Provost, and O. Ronin. 1994. Mechanisms and clinical impact of antifungal drug resistance. J. Med. Vet. Mycol. 32:189-202.
25. Walsh, T. J., V. Petraitis, R. Petraitiene, A. Field-Ridley, D. Sutton, M. Ghannoum, T. Sein, R. Schaufele, J. Peter, J. Bacher, H. Armstrong, A. Espinel-Ingroff, M. G. Rinaldi, and C. A. Lyman. 2003. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. J. Infect. Dis. 188:305-319.